Financhill
Back

Veris Residential Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
61

VRE
Veris Residential

Last Price:
$16.59
Seasonality Move:
11.48%
Buy
52

SRPT
Sarepta Therapeutics

Last Price:
$73.63
Seasonality Move:
14.66%
Buy
61
Veris Residential (VRE) is a Buy

Is Veris Residential a Buy, Sell or Hold?

  • The current Veris Residential [VRE] share price is $16.64. The Score for VRE is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • VRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $76.33. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VRE Stock Price Chart

What is Veris Residential's stock price today?

  • The Veris Residential share price today is $16.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRE is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $76.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 57.23 Buy
Chaikin Money Flow: 433826 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.9 - 16.66) Buy
Bollinger Bands (100): (15.86 - 17.6) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.07 Sell
Relative Strength Index (14 RSI): 30.8 Sell
Chaikin Money Flow: 1304026 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.54 - 110.54) Sell
Bollinger Bands (100): (102.23 - 127.85) Sell

VRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.31 Buy
20-day SMA: 16.4 Buy
50-day SMA: 16.09 Buy
200-day SMA: 16.53 Buy
8-day EMA: 16.39 Buy
20-day EMA: 16.32 Buy
50-day EMA: 16.34 Buy
200-day EMA: 16.41 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.29 Sell
20-day SMA: 96.26 Sell
50-day SMA: 107.61 Sell
200-day SMA: 124.92 Sell
8-day EMA: 82.75 Sell
20-day EMA: 92.99 Sell
50-day EMA: 104.03 Sell
200-day EMA: 117.97 Sell

Veris Residential Earnings Growth & VRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Veris Residential Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):